Minocycline Hydrochloride
FDA-approved product (capsule, oral), marketed as Amzeeq, Arestin, Dynacin and 7 more.
- Registered studies
- 50+
- Lab records
- 26
- Pathogens at ≥40%
- 4 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Acne
- Bacterial disease
- Conjunctivitis
- Infection
- Ornithosis
- Periodontitis
- Respiratory tract infectious disorder
- Rosacea
- Spotted fever
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Antiinfectives and antiseptics for local oral treatment; Antiinfectives for treatment of acne; Tetracyclines
- Anti-infective classification
- Classified as an existing antimicrobial.WHO ATC D10AF07; WHO ATC J01AA08
Repurposing investigation
Minocycline Hydrochloride is already an antimicrobial, so it is not counted among the repurposing candidates. Its AI-predicted activity is shown below for reference.
AI-predicted activity
AI prediction · nothing measured- MRSA89.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- E. coli89.7% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- K. pneumoniae98.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- M. tuberculosis80.3% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
- MRSA: measured active in 4 of 4 lab records
- E. coli: measured active in 3 of 3 lab records
- K. pneumoniae: measured active in 14 of 17 lab records
- M. tuberculosis: measured active in 2 of 2 lab records
Show the 26 laboratory records, with sources
Loading records…
“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Minocycline Hydrochloride with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Galantamine HydrobromideExisting use: Alzheimer disease, Dementia89.6% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- Chlorhexidine GluconateExisting use: Eye infection, Gingivitis, Infection and 2 more69.3% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives68.0% AI-predicted activityagainst K. pneumoniaeLab records exist50+ registered studies
- ElvitegravirExisting use: HIV infection, HIV-1 infection, Viral disease60.2% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more57.5% AI-predicted activityagainst K. pneumoniae50+ registered studies
- DactinomycinExisting use: Kidney Wilms tumor, Neoplasm56.8% AI-predicted activityagainst K. pneumoniae50+ registered studies
- CyclosporineExisting use: Conjunctivitis, Corneal disease, Eye disease and 6 more56.1% AI-predicted activityagainst K. pneumoniae50+ registered studies
- LinaclotideExisting use: Constipation, Constipation disorder, Irritable bowel syndrome56.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Irinotecan HydrochlorideExisting use: Adenocarcinoma, Cancer, Carcinoma and 4 more54.5% AI-predicted activityagainst K. pneumoniae50+ registered studies
- OxytocinExisting use: Hemorrhage, Uterine Inertia52.7% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Micafungin SodiumExisting use: Candidiasis52.4% AI-predicted activityagainst K. pneumoniae50+ registered studies
- VoclosporinExisting use: Immune system disease, Lupus nephritis52.2% AI-predicted activityagainst K. pneumoniae28 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression
NCT01574742 · start 2012-06
Registered record
- Registry ID
- NCT01574742
- Conditions
- Unipolar Depression
- Interventions
- Minocycline
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Unknown
- Start
- 2012-06
- Completion
- 2014-06
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionUnipolar DepressionInterventionMinocyclinePhasePhase 1Registry statusUnknownNovel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
NCT01695291 · start 2012-05
Registered record
- Registry ID
- NCT01695291
- Conditions
- Obsessive Compulsive Disorder
- Interventions
- Minocycline; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2012-05
- Completion
- 2018-05
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObsessive Compulsive DisorderInterventionMinocycline; PlaceboPhasePhase 2Registry statusCompletedMinocycline Augmentation in Schizophrenia
NCT01561742 · start 2012-02
Registered record
- Registry ID
- NCT01561742
- Conditions
- Schizophrenia
- Interventions
- Minocycline; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2012-02
- Completion
- 2015-01
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSchizophreniaInterventionMinocycline; PlaceboPhaseNot applicableRegistry statusUnknownEffect of Minocycline on Pain Caused by Nerve Damage
NCT01869907 · start 2011-09
Registered record
- Registry ID
- NCT01869907
- Conditions
- Neuropathic Pain Caused by Lumbar Radicular Pain
- Interventions
- Minocycline; placebo; Amitriptyline
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2011-09
- Completion
- 2014-08
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNeuropathic Pain Caused by Lumbar Radicular PainInterventionMinocycline; placebo; AmitriptylinePhasePhase 4Registry statusCompletedBioequivalence Minocycline Bioequivalence
NCT01755611 · start 2011-06-17
Registered record
- Registry ID
- NCT01755611
- Conditions
- Skin Infections (Acne)
- Interventions
- Minocycline 100mg; Minocycline 100mg
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2011-06-17
- Completion
- 2011-06-25
- Enrolment
- 25
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSkin Infections (Acne)InterventionMinocycline 100mg; Minocycline 100mgPhasePhase 1Registry statusCompletedEfficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea
NCT05014906 · start 2010-05
Registered record
- Registry ID
- NCT05014906
- Conditions
- Rosacea
- Interventions
- Minocycline 45 MG; Azelaic acid
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2010-05
- Completion
- 2011-09
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionRosaceaInterventionMinocycline 45 MG; Azelaic acidPhasePhase 4Registry statusCompletedTrial of Minocycline to Treat Children With Fragile X Syndrome
NCT01053156 · start 2010-01
Registered record
- Registry ID
- NCT01053156
- Conditions
- Fragile X Syndrome
- Interventions
- minocycline hydrochloride; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-01
- Completion
- 2011-12
- Enrolment
- 66
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFragile X SyndromeInterventionminocycline hydrochloride; PlaceboPhaseNot applicableRegistry statusCompletedMinocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage
NCT02113176 · start 2010-01
Registered record
- Registry ID
- NCT02113176
- Conditions
- Subarachnoid Aneurysm Hemorrhage
- Interventions
- Minocycline
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Withdrawn
- Start
- 2010-01
- Completion
- 2018-12
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSubarachnoid Aneurysm HemorrhageInterventionMinocyclinePhasePhase 1 / Phase 2Registry statusWithdrawnSafety and Efficacy Comparison of Minocycline Microgranules Versus Lymecycline in the Treatment of Mild to Moderate Acne
NCT00988026 · start 2009-06
Registered record
- Registry ID
- NCT00988026
- Conditions
- Mild to Moderate Acne
- Interventions
- Minocycline vs Lymecycline
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2009-06
- Completion
- 2010-04
- Enrolment
- 168
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMild to Moderate AcneInterventionMinocycline vs LymecyclinePhasePhase 4Registry statusUnknownGranuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
NCT00720980 · start 2008-05
Registered record
- Registry ID
- NCT00720980
- Conditions
- Granuloma Annulare
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2008-05
- Completion
- 2008-07
- Enrolment
- 6
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionGranuloma AnnulareInterventionNot recordedPhaseNot recordedRegistry statusCompletedLong-term Safety of Minocycline in Patients With Gum Disease
NCT00668746 · start 2007-12
Registered record
- Registry ID
- NCT00668746
- Conditions
- Periodontitis
- Interventions
- Minocycline HCl microspheres
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2007-12
- Completion
- 2009-02
- Enrolment
- 35
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPeriodontitisInterventionMinocycline HCl microspheresPhasePhase 4Registry statusCompletedIntrapleural Minocycline After Aspiration of Spontaneous Pneumothorax
NCT00839553 · start 2007-04
Registered record
- Registry ID
- NCT00839553
- Conditions
- Pneumothorax
- Interventions
- Intrapleural Minocycline application
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2007-04
- Completion
- 2009-04
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumothoraxInterventionIntrapleural Minocycline applicationPhaseNot applicableRegistry statusUnknownMinocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
NCT00361257 · start 2007-03
Registered record
- Registry ID
- NCT00361257
- Conditions
- HIV Infections
- Interventions
- Minocycline; Placebo (Tetracycline)
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Terminated
- Start
- 2007-03
- Completion
- 2010-01
- Enrolment
- 107
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHIV InfectionsInterventionMinocycline; Placebo (Tetracycline)PhasePhase 2Registry statusTerminatedA Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 · start 2006-08
Registered record
- Registry ID
- NCT01049438
- Conditions
- Methicillin Resistant Staphylococcus Aureus Skin Infections
- Interventions
- nasal mupirocin; topical 3% hexachlorophene body wash; oral anti-MRSA antibiotic
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2006-08
- Completion
- 2009-09
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin Resistant Staphylococcus Aureus Skin InfectionsInterventionnasal mupirocin; topical 3% hexachlorophene body wash; oral anti-MRSA antibioticPhaseNot applicableRegistry statusCompletedCombination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
NCT00355576 · start 2006-07
Registered record
- Registry ID
- NCT00355576
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Celecoxib; Creatine; Minocycline
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2006-07
- Completion
- 2007-05
- Enrolment
- 86
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAmyotrophic Lateral SclerosisInterventionCelecoxib; Creatine; MinocyclinePhasePhase 2Registry statusCompleted